Study of BEBT-908 in Subjects With Advanced Hematological Tumors

NCT06082596 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed or Refractory Non-Hodgkin's Lymphoma
Relapsed or Refractory Multiple Myeloma

Interventions

DRUG: BEBT-908 for injection

Sponsor

BeBetter Med Inc